Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2026)
Twist Bioscience (TWST) has 10 years of Gains from Investment Securities data on record, last reported at -$24.8 million in Q1 2026.
- On a quarterly basis, Gains from Investment Securities fell 825633.33% to -$24.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1000.0, a 100.08% increase, with the full-year FY2024 number at -$994000.0, up 83.19% from a year prior.
- Gains from Investment Securities reached -$24.8 million in Q1 2026 per TWST's latest filing, down from $24.8 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for TWST hit a ceiling of $24.8 million in Q4 2025 and a floor of -$24.8 million in Q1 2026.
- A 5-year average of -$1.4 million and a median of -$444000.0 in 2022 define the central range for Gains from Investment Securities.
- Peak YoY movement for Gains from Investment Securities: surged 825666.67% in 2025, then plummeted 825633.33% in 2026.
- Tracing TWST's Gains from Investment Securities over 5 years: stood at $52000.0 in 2022, then tumbled by 676.92% to -$300000.0 in 2023, then soared by 101.0% to $3000.0 in 2024, then soared by 825666.67% to $24.8 million in 2025, then plummeted by 200.0% to -$24.8 million in 2026.
- Business Quant data shows Gains from Investment Securities for TWST at -$24.8 million in Q1 2026, $24.8 million in Q4 2025, and -$603000.0 in Q3 2025.